Dr. Garrett is a clinician and researcher, with interests in: vascular dementia, non-pharmaceutical treatments for dementia, interventions to support primary care physicians in cognitive care, and mental health integrated primary care practices. She is a co-developer of the Philadelphia Repeatable Verbal Learning Test, as well as process approach methods to interpretation of errors in memory and executive function measures. She was Principal Investigator of a prospective randomized control trial of physical exercise as a treatment for the cognitive disability associated with Alzheimer's disease, The Brain Builders. She mentors graduate and medical students in her clinical practice and research projects. She has served on the board of directors of both the Utah Chapter of the Alzheimer's Association and the Brain Injury Association of Utah.
- Leukoaraiosis severity and list-learning in dementia. Price CC, Garrett KD, Jefferson AL, Cosentino S, Tanner JJ, Penney DL, Swenson R, Giovannetti T, Bettcher BM, Libon DJ. Clin Neuropsychol. 2009 Aug;23(6):944-61. Defining the diagnosis of vascular dementia. Garrett KD, Paul RH, Libon DJ, Cohen RA. Appl Neuropsychol. 2004;11(4):204-9. Review.
- From Binswanger's disease to leuokoaraiosis: what we have learned about subcortical vascular dementia. Libon DJ, Price CC, Davis Garrett K, Giovannetti T. Clin Neuropsychol. 2004 Feb;18(1):83-100. Review.
- Computer-mediated measurement and subjective ratings of white matter hyperintensities in vascular dementia: relationships to neuropsychological performance. Davis Garrett K, Cohen RA, Paul RH, Moser DJ, Malloy PF, Shah P, Haque O. Clin Neuropsychol. 2004 Feb;18(1):50-62.
- The clinical diagnosis of vascular dementia: A comparison among four classification systems and a proposal for a new paradigm. Cosentino SA, Jefferson AL, Carey M, Price CC, Davis-Garrett K, Swenson R, Libon DJ. Clin Neuropsychol. 2004 Feb;18(1):6-21.
- The neuropsychological profile of vascular cognitive impairment--no dementia: comparisons to patients at risk for cerebrovascular disease and vascular dementia. Garrett KD, Browndyke JN, Whelihan W, Paul RH, DiCarlo M, Moser DJ, Cohen RA, Ott BR. Arch Clin Neuropsychol. 2004 Sep;19(6):745-57.